Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/02/2024 | Q1 2024 | -$0.05 | $535.68 M | 12/30/2023 | Q4 2023 | $0.02 | $0 | 09/29/2023 | Q3 2023 | $0.03 | $0 | 06/29/2023 | Q2 2023 | -$0.40 | $0 | 03/30/2023 | Q1 2023 | -$0.59 | $0 | 12/30/2022 | Q4 2022 | -$0.18 | $0 | 09/29/2022 | Q3 2022 | -$0.01 | $0 | 06/28/2022 | Q2 2022 | -$0.01 | $0 | 03/30/2022 | Q1 2022 | -$0.00 | $0 |
---|
A. The conference call for Conduit Pharmaceuticals Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Conduit Pharmaceuticals Inc.'s latest earnings report can be read online.
A. Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) has a recorded net income of $0. Conduit Pharmaceuticals Inc. has generated $-0.008 earnings per share over the last four quarters.